Skip to content
EN
DE
*protected email*
+49 211 942 522 98
Toggle Navigation
About us
Technology
Pipeline
Working with us
Partnering & Investing
Careers
Media
News & Events
Press
Philipp.Buerling
Categories
Philipp.Buerling
24
Philipp.Buerling
24
Philipp.Buerling
24
News, Press Release
Priavoid receives funding from the Alzheimer’s Association and the Rainwater Charitable Foundation to further develop its tau program
Continue reading
News, Press Release
New Alzheimer’s drug PRI-002 receives EMA approval for Phase II study
Continue reading
News
Priavoid selected to German Accelerator Program
Continue reading
Event
Prion 2022, Göttingen, 13-16 September
Continue reading
Event
Bio International, San Diego, 13-16 June
Continue reading
Event
Neuro4D, Mainz, 16-17 May
Continue reading
1
2
Next
Page load link